Foundational Principles of Calcium and Magnesium Abnormalities in Critical Illness

1. Epidemiology and Incidence

Calcium and magnesium disturbances are among the most common electrolyte abnormalities in the ICU and correlate with adverse outcomes. Early recognition in high-risk cohorts, such as patients receiving massive blood transfusions, those on loop diuretics or proton-pump inhibitors, and the malnourished, enables timely prevention and treatment.

Key Points:

• Routine measurement of ionized calcium and serum magnesium is crucial for detecting dual deficiencies early.
• Hypomagnesemia often coexists with hypocalcemia and impairs parathyroid hormone (PTH) action, delaying calcium correction.

2. Calcium Homeostasis Mechanisms

Parathyroid hormone (PTH), vitamin D, renal handling, and bone remodeling tightly regulate serum calcium within narrow limits. Disruptions in this intricate system lead to clinically significant derangements.

• pH and Phosphate Effects: Alkalosis increases albumin-bound calcium, thereby lowering the physiologically active ionized fraction. Hyperphosphatemia can precipitate with calcium, also reducing the ionized level.

3. Magnesium Homeostasis Mechanisms

Magnesium is a predominantly intracellular cation, and its homeostasis is a balance between gastrointestinal absorption, distribution between compartments, and renal excretion. Serum levels represent only 1% of total body stores, making them a poor proxy for overall magnesium status.

Functional Roles:

• Acts as a natural physiological calcium channel antagonist.
• Essential cofactor for hundreds of enzymatic reactions, including ATP synthesis and use.
• Modulates neuromuscular excitability and systemic vascular tone.

4. Pathophysiology of Calcium Abnormalities

Hypocalcemia and hypercalcemia result from disruptions in protein binding, hormone regulation, and renal or bone handling.

A. Hypocalcemia Etiologies

• Citrate Chelation: Citrate in transfused blood products binds ionized calcium, reducing its availability.
• Functional Hypoparathyroidism: Hypomagnesemia impairs PTH secretion and target-organ responsiveness. Sepsis and systemic inflammation can also blunt PTH release.
• Binding and Precipitation: Alkalosis increases albumin binding, while hyperphosphatemia causes calcium phosphate precipitation.

B. Hypercalcemia Etiologies

• Malignancy: Most common cause in hospitalized patients, via PTH-related peptide (PTHrP) secretion or direct osteolytic metastases.
• Primary Hyperparathyroidism: Autonomous PTH secretion from an adenoma.
• Other Causes: Vitamin D intoxication, granulomatous diseases (e.g., sarcoidosis), immobilization, and thiazide diuretic use.

5. Pathophysiology of Magnesium Abnormalities

Magnesium disturbances profoundly affect the neuromuscular and cardiovascular systems. Hypomagnesemia is particularly insidious as it often manifests with other electrolyte derangements.

A. Hypomagnesemia Etiologies

• Gastrointestinal Losses: Vomiting, diarrhea, high-output fistulas, or nasogastric suction.
• Renal Wasting: Loop and thiazide diuretics, proton-pump inhibitors, and certain nephrotoxic drugs.
• Malabsorption Syndromes: Chronic pancreatitis, inflammatory bowel disease, or short bowel syndrome.

B. Hypermagnesemia Etiologies

• Impaired Excretion: Acute or chronic kidney injury is the most common cause.
• Excessive Intake: Overuse of magnesium-containing laxatives or antacids, or iatrogenic overdose during treatment for eclampsia or arrhythmias.

6. Clinical Manifestations

Calcium and magnesium imbalances produce characteristic neuromuscular, cardiovascular, and respiratory signs that guide diagnosis and management. In patients with unexplained refractory arrhythmias or muscle weakness, both electrolytes should be measured concurrently.

Neuromuscular Effects

• Hypocalcemia/Hypomagnesemia: Paresthesias, tetany (e.g., positive Chvostek/Trousseau signs), hyperreflexia, and seizures.
• Hypercalcemia/Hypermagnesemia: Muscle weakness, fatigue, and diminished or absent deep-tendon reflexes.

Cardiovascular Effects

• Hypocalcemia: QT interval prolongation, impaired contractility, and risk of ventricular arrhythmias.
• Hypercalcemia: QT interval shortening and bradyarrhythmias.
• Hypomagnesemia: PR and QT interval prolongation, torsades de pointes.
• Hypermagnesemia: Hypotension, sinus bradycardia, and advanced heart block.

7. Impact of Chronic Diseases

Chronic conditions like kidney disease, cystic fibrosis, and malnutrition create a state of mineral dyshomeostasis that increases vulnerability during acute critical illness.

CKD and Dialysis

Phosphate retention and impaired activation of vitamin D lead to secondary hyperparathyroidism and complex bone mineral disorders. Magnesium accumulation is common in advanced CKD, requiring careful management of dialysate magnesium concentration to avoid toxicity.

Cystic Fibrosis & Malnutrition

Fat malabsorption reduces the uptake of vitamin D and magnesium. Altered calcium-to-magnesium ratios contribute to poor bone mineralization and other metabolic complications. It is important to monitor these ratios to guide appropriate supplementation.

8. Social Determinants of Health

Socioeconomic factors, health literacy, and barriers to access can directly impact the prevention and treatment of electrolyte disorders, both chronically and in the acute setting.

• Medication and Food Access: Financial and insurance barriers may limit access to necessary supplements. Food insecurity and diets low in dairy, nuts, and leafy greens predispose individuals to chronic deficiencies.
• Health Literacy: An inadequate understanding of supplementation regimens, dietary sources, and the importance of adherence can hinder effective management.